LODE
Q4 2026 EPS Estimate
$0.06
Oct 29, 2026
Revenue Estimate
$2M
FY2028E EPS$0.24
FY2029E EPS$1.00

Analyst Sentiment

Wall St. Consensus
Buy
5 analysts·Limited coverage
65
Score
3 Buy (60%)2 Hold (40%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
360%
Hold
240%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

No analyst price targets available for LODE

Analyst coverage may not be available for this symbol

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+410.04%
EPS
FY2028
Rev+161.13%
EPS
FY2029
Rev+80.78%
EPS+316.67%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027EFY2028EFY2029EFY2030E
Revenue Avg$6M$32M$84M$151M$205M
Low$6M$32M$84M$151M$205M
High$6M$32M$84M$151M$205M
EBITDA Avg$-4M$-19M$-50M$-91M$-123M
Low$-4M$-19M$-50M$-91M$-123M
High$-4M$-19M$-50M$-91M$-123M
EBIT Avg$-4M$-19M$-50M$-91M$-123M
Low$-4M$-19M$-50M$-91M$-123M
High$-4M$-19M$-50M$-91M$-123M
Net Income Avg$-20M$-14M$9M$37M$62M
Low$-20M$-14M$9M$37M$62M
High$-20M$-14M$9M$37M$62M
EPS Avg$-0.54$-0.37$0.24$1.00$1.68
Low$-0.54$-0.37$0.24$1.00$1.68
High$-0.54$-0.37$0.24$1.00$1.68
Analysts (Rev / EPS)1 / 11 / 11 / 11 / 11 / 1
Quarterly
MetricQ3 2026Q4 2026Q1 2027Q2 2027Q3 2027Q4 2027
Revenue Avg$2M$3M$17M$22M$27M$32M
Low$2M$3M$17M$22M$27M$32M
High$2M$3M$17M$22M$27M$32M
EBITDA Avg$-1M$-2M$-10M$-13M$-16M$-19M
Low$-1M$-2M$-10M$-13M$-16M$-19M
High$-1M$-2M$-10M$-13M$-16M$-19M
EBIT Avg$-1M$-2M$-10M$-13M$-16M$-19M
Low$-1M$-2M$-10M$-13M$-16M$-19M
High$-1M$-2M$-10M$-13M$-16M$-19M
Net Income Avg$5M$-9M$9M$14M$20M$25M
Low$5M$-9M$9M$14M$20M$25M
High$5M$-9M$9M$14M$20M$25M
EPS Avg$0.06$-0.12$0.12$0.19$0.26$0.33
Low$0.06$-0.12$0.12$0.19$0.26$0.33
High$0.06$-0.12$0.12$0.19$0.26$0.33
Analysts (Rev / EPS)1 / 11 / 11 / 11 / 11 / 11 / 1

Earnings Surprises

Recent Analyst Actions

No recent analyst actions

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.